ADVOCATE LUTHERAN GENERAL HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $4.4M
- Transactions
- 726
- Companies
- 40
- Average per transaction
- $6,053
Who reported the payments
| Amgen | $816,484 |
| Biogen | $567,792 |
| Hoffmann-la Roche Limited | $491,540 |
| Merck | $440,659 |
| Pfizer | $434,017 |
| Eisai Inc. | $389,587 |
| Incyte Corporation | $349,757 |
| E.r. Squibb & Sons, L.L.C. | $228,062 |
| Medtronic | $100,178 |
| Genentech, Inc. | $54,252 |
| Mirati Therapeutics, Inc. | $53,281 |
| Boehringer Ingelheim | $52,500 |
| Stryker | $36,219 |
| Takeda Pharmaceuticals U.S.A., Inc. | $35,214 |
| Edwards Lifesciences | $33,495 |
| Mallinckrodt Enterprises LLC | $30,000 |
| Covidien LP | $30,000 |
| Shockwave Medical, Inc | $29,072 |
| Roche Products Limited | $27,771 |
| AbbVie | $21,746 |
| AstraZeneca | $18,750 |
| Rapid Medical Ltd | $14,489 |
| Karyopharm Therapeutics Inc. | $10,328 |
| Cagent Vascular Inc | $9,350 |
| Biotronik Inc. | $8,937 |
| Bard Peripheral Vascular, Inc. | $8,188 |
| Puma Biotechnology, Inc. | $7,500 |
| AMAG Pharmaceuticals, Inc. | $7,000 |
| KARL Storz Endoscopy-america | $6,694 |
| National Marrow Donor Program | $6,655 |
| CSL Behring | $6,484 |
| Teva Pharmaceuticals USA, Inc. | $6,008 |
| Medical Device Business Services, Inc. | $6,000 |
| Siemens Medical Solutions USA, Inc. | $5,863 |
| Microvention, Inc. | $5,327 |
| Exact Sciences | $4,845 |
| Kls-martin L.p. | $4,232 |
| Novartis | $4,000 |
| Acell, Inc. | $3,714 |
| Hologic Inc | $3,164 |